Menu Search
Equities

Groep Brussel Lambert NV

GBLB:VIE

Groep Brussel Lambert NV

Actions
  • Price (--)--
  • Today's Change--
  • Shares traded--
  • 1 Year change--
  • Beta--
--
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Groep Brussel Lambert NV is a Belgium-based investment holding company. The Company has a diversified portfolio composed of global companies, such as Imerys, Adidas, Pernod Ricard, LafargeHolcim, Umicore and Ontex, among others. It operates under three business segments, such as Holding, which comprises the parent company and subsidiaries. Its main activity is to manage investments as well as the non-consolidated operating companies and associates. Its Imerys, which consists of the Imerys group engaged in energy solutions & specialities, filtration & performance additives, ceramic materials, high resistance minerals and sienna capital.

  • Revenue in EUR (TTM)6.70bn
  • Net income in EUR52.00m
  • Incorporated1983
  • Employees69.00
  • Location
    Groep Brussel Lambert NVAvenue Marnix 24BRUXELLES 1000BelgiumBEL
  • Phone+32 22891717
  • Fax+32 22891737
  • Websitehttps://www.gbl.be/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.